Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary Report

<div>The differences in tryptase, PDGF, soluble c-kit, ET-1, and angiogenin levels among patients with 1-, 2-, and 3-vessel CAD. The analysis was made using <svg height="7.94193pt" id="M14" style="vertical-align:-0.2063999pt" version="1.1" viewbox="-0.0498162 -7.73553 4.62753 7.94193" width="4.62753pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M329 433H203L239 587L230 596L147 534L123 433H57L30 395L34 388H115L61 129C37 16 59 -12 85 -12C147 -12 222 58 260 98L241 125C212 95 160 62 144 62C132 62 127 71 138 126L192 386L305 394L329 433Z" id="g50-117"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="347" vert-adv-y="347"></glyph.data></g></svg>-test.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary Report 